INSIDER
US-China research has given Beijing's military technology a boost, House GOP says
Read full article: US-China research has given Beijing's military technology a boost, House GOP saysA new report by congressional Republicans asserts that partnerships between the U.S. and China at universities over the past decade have allowed hundreds of millions of dollars in federal funding to aid Beijing in developing critical technology that could be used for military purposes.
Viral and vital, college gymnasts finding their voice
Read full article: Viral and vital, college gymnasts finding their voiceThe social justice movement in college athletics has popped up in most unusual place: gymnastics. From UCLA to Pittsburgh, Black gymnasts and the programs they represent are using their platform to empower and uplift. Her experience at Arkansas was simply reflective of the culture at large in the sport at the time. From Pittsburgh to California, female gymnasts are using their platform to empower, educate and bring light to causes they believe in. “Personally I would say (gymnastics) is a predominantly white sport,” Ward said.
The University of Pittsburgh acquires August Wilson trove
Read full article: The University of Pittsburgh acquires August Wilson troveNEW YORK – The University of Pittsburgh has acquired the archive of the late playwright and Pittsburgh native son August Wilson, a trove that contains recordings, letters, artwork, poetry, unpublished work and notebooks. The August Wilson Archive will reside in a state-of-the-art home in Hillman Library’s renovated Archives & Special Collections, the university said Thursday. “This acquisition is about more than bringing August Wilson back home to Pittsburgh,” said Chancellor Patrick Gallagher in a statement. Next up this December is “Ma Rainey’s Black Bottom,” directed by Tony-winner George C. Wolfe and adapted by Ruben Santiago-Hudson. Washington says “The Piano Lesson” is the next Wilson work he hopes to bring to the screen.
Michigan Medicine awarded funding for COVID-19 plasma therapy trial
Read full article: Michigan Medicine awarded funding for COVID-19 plasma therapy trialANN ARBOR, Mich. Researchers at the University of Michigans Michigan Medicine and three other medical centers were awarded a total of $7 million from the National Heart, Lung, and Blood Institute (NHBLI) to study convalescent plasma in reducing symptoms of COVID-19 in patients with mild cases, Michigan Medicine announced Thursday. The other medical centers awarded funding are the University of Pittsburgh, Medical University of South Carolina and Stanford Medicine. As part of NHBLIs initiative, the Clinical Trial of COVID-19 Convalescent Plasma of Outpatients (C3PO), the institute plans to study whether preventing a mild case from becoming severe can come from passive immunization. Convalescent plasma contains antibodies that can bind to the virus that causes COVID-19, neutralizing it. A press release from Michigan Medicine said convalescent plasma can be used as a treatment for hospital patients with severe to life-threatening COVID-19, which is the passive immunization.
Michigan Medicine part of $7 million in funding for COVID-19 therapy trial
Read full article: Michigan Medicine part of $7 million in funding for COVID-19 therapy trialANN ARBOR, Mich. Researchers at the University of Michigans Michigan Medicine and three other medical centers were awarded a total of $7 million from the National Heart, Lung, and Blood Institute (NHBLI) to study convalescent plasma in reducing symptoms of COVID-19 in patients with mild cases, Michigan Medicine announced Thursday. ORIGINAL STORY: Michigan Medicine awarded funding for COVID-19 plasma therapy trialMost of the other studies are focused on people who are so sick that they need to be in the ICU, said Dr. Frederick Korley. He said convalescent plasma -- donated by survivors -- contains antibodies that can bind to COVID-19 and neutralize it. Our hope is that if we can get to the patient early enough then -- with convalescent plasma -- we can neutralize the virus before the virus does a lot of damage to the body, Korley said. The study will enroll ER patients that have mild COVID-19 symptoms, but a high-risk for developing severe complications.